Company and People Notes: Chesapeake to Relocate and Expand, AVI BioPharma Appoints CEO, More

Novo Nordisk to Make Multi-Billion Dollar Investment in Expansion of Production Facilities in France

New Medicines, Markets, and Manufacture: CRISPR for Sickle Cell Disease and β-thalassemia

TAU Systems to Establish TAU Labs, a New Laser Plasma Accelerator Application Center